TAKEDA PHARMACEUTICAL CO LTD
Business
Takeda Pharmaceutical Co Ltd is a global R&D-driven biopharmaceutical company that discovers and delivers treatments across gastrointestinal and inflammation, neuroscience, oncology, plasma-derived therapies, and vaccines. Principal marketed products include ENTYVIO for inflammatory bowel disease, TAKHZYRO for hereditary angioedema, immunoglobulin therapies, and oncology medicines such as ADCETRIS and NINLARO. The company operates through regional business units in the U.S., Japan, Europe, and emerging markets including China, with a geographically diversified manufacturing and research footprint.
Summary from 20-F filed 2026-06-17
Financials
Latest annual snapshot (FY2026, period end 2026-03-31). Full statement history unavailable for this entity.
| Revenue | — |
| Net income | $-152.13B |
| Total assets | $15.51T |
| Total liabilities | $8.08T |
| Stockholders' equity | — |
| Operating cash flow | — |
Filings
Material Events
Insiders
Institutional Holders
Holdings (13F)
Portfolio as of 2025-09-30 · 9 positions
Top sectors
| Sector | Value | % of portfolio |
|---|---|---|
| Uncategorized | $16.37M | 100.0% |
Top holdings
| Issuer | Ticker | Shares | Value | % |
|---|---|---|---|---|
| Ovid Therapeutics, Inc. | — | 5.75M | $7.47M | 45.7% |
| Equillium, Inc. | — | 1.82M | $2.61M | 15.9% |
| Ovid Therapeutics, Inc. | — | 1.78M | $2.32M | 14.2% |
| Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics) | — | 1.48M | $1.24M | 7.6% |
| Shattuck Labs, Inc. | — | 515.6K | $1.23M | 7.5% |
| Lyell Immunopharma, Inc. | — | 54.9K | $891.0K | 5.4% |
| American Well Corporation | — | 77.7K | $478.0K | 2.9% |
| Rani Therapeutics Holdings, Inc. | — | 203.2K | $101.0K | 0.6% |
| Standard Biotools, Inc. | — | 16.5K | $21.0K | 0.1% |
Frequently asked questions
What is TAKEDA PHARMACEUTICAL CO LTD's CIK number?
TAKEDA PHARMACEUTICAL CO LTD's SEC CIK number is 0001395064 (1395064). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find TAKEDA PHARMACEUTICAL CO LTD's SEC filings?
All of TAKEDA PHARMACEUTICAL CO LTD's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.